טוען...
The affect of goserelin on the QoL of women having chemotherapy for EBC: Results from the OPTION trial
BACKGROUND: The OPTION trial results showed that premenopausal women with early stage breast cancer (EBC) receiving chemotherapy benefited from ovarian function protection with goserelin. The impact of treatments on patient reported Quality of Life (QoL) were also examined. PATIENTS AND METHODS: 227...
שמור ב:
| הוצא לאור ב: | Breast |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7303950/ https://ncbi.nlm.nih.gov/pubmed/32505861 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2020.05.009 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|